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Background
Neglected data more or less recent, showed that the vol-
tage-dependent sodium channel (Tran MKG) and the
Mannose receptor [Bandivdekar AH 14°ISHEID Toulon
2006 (PP 2.14); J Acquir.Immune.Defic.Syndr.2008,Virol-
ogy.2008] are involved in the transmission of HIV. In
particular, the mannose Receptor seem essential for con-
tamination since in a discordant couple, the uninfected
male partner does not own this receptor (14° ISHEID,
Bandivdekar A.H.). From these facts we have experienced
a patient of 68 years, HIV + since 28 years, under active
antiretroviral therapy (Epivir, Reyataz, resveratrol)
(another presentation at this conference), the following
chemotherapy: Epivir (150mg 2daily), resveratrol (500mg
2daily), D-Mannose (1 g 3daily), Omacor (1 g 2daily).
Indeed it is known that omega-3fatty acids bind the Na+
channel. Resveratrol has an anti TaT activity (Zhang
HS,2009) and a synergy with nucleoside analogues
((HerediaA,2008.)
Methods
Measurements of viral load , CD4 and CD8 and other
usual blood parameters were followed during 9 months,
every month.
Results
Our results show that over a period of 9 months the
patient remains undetectable and CD4 count increases sig-
nificantly from the one of the previous therapy (557+/-43
vs 478+/- 35). Besides, it seems that the CD4/CD8 ratio
tended to increase (0.61 vs 0,56 ). Moreover strong activa-
tion of the immune system almost always observed among
patients HIV+ is standardized at this patient (CD3
+/HLADR+ 7%) and the NK strongly increase (24%).
Conclusion
Our results show the feasibility of HAART including
Epivir, resveratrol, D-mannose, and omega3 fatty acids.
In addition control of dyslipidemia induced by ortho-
doxic anti retrovirals should be unnecessary.These
results paves the way for clinical trials with effective,
low toxicity and low cost agents. Moreover the fact that
mutations on the Mannose receptor and sodium chan-
nel (cell structures) are unlikely, make the appearance of
resistance to such therapies unlikely.
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